Merceditas Villanueva
Dados Biográficos
| ID | 7450737 |
|---|---|
| NOME | Merceditas Villanueva |
| PRENOMES | Merceditas |
| SOBRENOME | Villanueva |
| ASSINATURA | VILLANUEVA M |
| AFILIAÇÕES | Yale University |
| ORCID | 0000-0003-1022-7746 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 6 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 6 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2022 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2025 |
| ÍNDICE H | 0 |
Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People with HIV in Project CoRect
Using the exploration, preparation, implementation, sustainment (Epis) framework to assess the cooperative re-engagement controlled trial (CoRect)
Background: "Data to Care" (D2C) is a strategy which relies on a combination of public health surveillance data supplemented by clinic data to support continuity of HIV care. The Cooperative Re-Engagement Controlled Trial (CoRECT) was a CDC-sponsored randomized controlled trial of a D2C model, which provided an opportunity to examine the process of implementing an intervention for people with HIV (PWH) who are out-of-care across three public heal…
Prevalence and Correlates of Physical Inactivity Among Individuals with HIV During the First Covid-19 Wave
Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs)
In the United States, approximately 25% of people with HIV (PWH) are co-infected with hepatitis C (HCV). Since 2014, highly effective and well-tolerated direct-acting antivirals (DAAs) have revolutionized HCV treatment. Uptake of DAAs by people with HIV/HCV co-infection has improved but remains suboptimal due to system, provider, and patient-level barriers. To explore patient-level issues by better understanding their attitudes towards DAA treatm…
Experiences with Telemedicine for HIV Care During the Covid-19 Pandemic
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the Covid-19 response
Sem obras proeminentes nesta página.
Perceptions Towards HCV Treatment with Direct Acting Antivirals (DAAs)
In the United States, approximately 25% of people with HIV (PWH) are co-infected with hepatitis C (HCV). Since 2014, highly effective and well-tolerated direct-acting antivirals (DAAs) have revolutionized HCV treatment. Uptake of DAAs by people with HIV/HCV co-infection has improved but remains suboptimal due to system, provider, and patient-level barriers. To explore patient-level issues by better understanding their attitudes towards DAA treatm…
Experiences with Telemedicine for HIV Care During the Covid-19 Pandemic
Treatment of Hepatitis C virus among people who inject drugs at a syringe service program during the Covid-19 response
Using the exploration, preparation, implementation, sustainment (Epis) framework to assess the cooperative re-engagement controlled trial (CoRect)
Background: "Data to Care" (D2C) is a strategy which relies on a combination of public health surveillance data supplemented by clinic data to support continuity of HIV care. The Cooperative Re-Engagement Controlled Trial (CoRECT) was a CDC-sponsored randomized controlled trial of a D2C model, which provided an opportunity to examine the process of implementing an intervention for people with HIV (PWH) who are out-of-care across three public heal…
Prevalence and Correlates of Physical Inactivity Among Individuals with HIV During the First Covid-19 Wave
Disease Intervention Specialist Field Experience in Re-engaging Out-of-Care People with HIV in Project CoRect
Medicine (6 obras) · Internal Medicine (5 obras) · Nursing (5 obras) · Health care (4 obras) · HIV/AIDS Research and Interventions (4 obras) · Public health (4 obras) · Coronavirus disease 2019 (COVID-19 (3 obras) · Family medicine (3 obras) · Health psychology (3 obras) · HIV, Drug Use, Sexual Risk (3 obras)